Close Menu

The Wall Street Journal's Hester Plumridge writes that personalized medicine offers advantages, but also poses challenges for pharmaceutical companies. Giving patients a drug that is known to be effective for their genetic profile not only will lower health care costs and limit adverse reactions, but also, Plumridge says, minimize the number of liability claims filed against pharma companies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Oil made from gene-edited soybeans is already in use, according to the Associated Press.

USA Today reports that Department of Veterans Affairs is teaming up with Sanford Health to provide veterans with genetic testing.

Mother Jones reports there are few regulations overseeing the use of genetic genealogy by law enforcement.

In Science this week: analysis of ancient DNA recovered from Iberian populations, and more.